Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002050709-26-000009·Squadron Capital Management LLC
Schedule 13G ownership disclosure
TRAWS PHARMA INC
Common Stock, par value $.01 per share · CUSIP: 68232V884
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Squadron Master Fund LP
Shares: 713,540.00 · Class: 8.9%
- Squadron Capital Management LLC
Shares: 713,540.00 · Class: 8.9%
- Matthew Sesterhenn
Shares: 713,540.00 · Class: 8.9%
- William Blank
Shares: 713,540.00 · Class: 8.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050709-26-000009
- Form type
- SCHEDULE 13G/A
- Filer
- Squadron Capital Management LLC
- CIK
- CIK 2050709
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership